Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 872 of 5804
-
New drug combo aims to outsmart lung cancer that resists immunotherapy
Disease control Not yet recruitingIntroduction: Patients with driver gene-negative non-small cell lung cancer (NSCLC) who experience treatment failure following immune checkpoint inhibitor (ICI) therapy have limited subsequent treatment options, representing an unmet clinical need. EGFR is commonly expressed in E…
Phase: PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New daily pill could help millions shed pounds
Disease control Recruiting nowThis master study protocol, Study D7260C00015, covers 2 independent, pivotal studies, Study 1 and Study 2. Each study is a global, randomized, double-blind, parallel-group, multicenter, Phase III study to assess the efficacy and safety of elecoglipron compared with placebo adjunc…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Blood test plus genetic score may sharpen recurrence prediction in endometrial cancer
Knowledge-focused OngoingThe goal of this observational study is to evaluate whether combining postoperative circulating tumor DNA (ctDNA) testing with a novel genomic risk model can better predict recurrence risk and guide adjuvant therapy decisions in patients with endometrial cancer. The main questio…
Sponsor: Guizhou Provincial People's Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
AI could spot difficult intubation risks from simple photos before surgery
Knowledge-focused OngoingThis prospective observational study will evaluate whether commonly available multimodal artificial intelligence models can predict difficult laryngoscopy and difficult intubation using standardized preoperative airway photographs. Adult patients scheduled for elective surgery re…
Sponsor: Memorial Atasehir Hospital • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New brain scan could spot Parkinson's earlier
Diagnosis Recruiting nowTo evaluate the potential usefulness of 18F-FPyCO/SMBT-1 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various MAO-B-related disease patients.
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
New drug aims to cut blood removal in rare cancer
Disease control Not yet recruitingPolycythemia vera (PV) is a rare blood cancer in which the body makes too many red blood cells. This can make the blood thicker and may increase the risk of serious health problems such as blood clots. Many people with PV need regular phlebotomy, which is a procedure to remove bl…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Cell injection could replace corneal transplants for blurry vision
Disease control Recruiting nowAssessment of safety and efficacy of cell injection therapy generated using non-cultured human corneal endothelial cells in treating corneal endothelial dysfunction
Phase: PHASE1 • Sponsor: Singapore Eye Research Institute • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Bile acid pill may turbocharge liver regrowth after transplant
Disease control Not yet recruitingThis placebo controlled randomized control study aims to analyze the effect of UDCA supplementation on liver regeneration in Living Donor Liver Transplant (LDLT) recipients. All eligible LDLT recipients during the study period will be included in the study and randomized into two…
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a Once-Daily pill ease nerve pain just as well as the standard Twice-Daily dose?
Symptom relief Recruiting nowExtended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia
Phase: PHASE3 • Sponsor: Brainfarma Industria Química e Farmacêutica S/A • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Breathing muscle training may boost heart failure recovery
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to compare the effects of three different modalities of inspiratory muscle training (IMT) in patients diagnosed with chronic heart failure who exhibit reduced or mid-range left ventricular ejection fraction (LVEF \< 50%). Patients will be recruited fr…
Phase: NA • Sponsor: Universidad Nacional Andres Bello • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a simple nasal device replace ventilators for COPD emergencies?
Disease control Recruiting nowThe purpose of this study is to determine whether nasal high flow is non inferior to non invasive ventilation (NIV) in the early treatment of patients with acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and hypercapnic acidosis in the emergency department (…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New insulin pump system aims to improve diabetes management
Disease control Not yet recruitingThis study will demonstrate the safety and performance of the Novel Medtronic Experimental Automated Insulin Delivery system named MiniMed™ NMX8 system in people living with insulin-requiring diabetes in comparison with the MiniMed™ 780G system.
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a painless electrical patch help cancer patients sleep better after surgery?
Symptom relief Not yet recruitingPostoperative sleep disturbance (POSD) is highly prevalent among cancer patients after tumor resection, affecting 43%-80% of perioperative individuals. Poor sleep aggravates postoperative pain, anxiety and adverse cardiovascular events, hindering postoperative recovery. Conventio…
Phase: NA • Sponsor: Second Hospital of Shanxi Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Experimental injection aims to boost platelets in chronic blood disorder
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study. The primary objective is to evaluate the safety and efficacy of SG301 SC Injection in participants with ITP, while the secondary objectives are to assess the pharmacokinetic, pharmacodyna…
Phase: PHASE2 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New pill could help restore skin color in vitiligo patients
Disease control Recruiting nowThis study tests D-2570, an investigational drug, in people with non-segmental vitiligo to check its safety and effect on skin discoloration. Eligible participants will take D-2570, or a placebo, once daily for 24 weeks in a double-blind setting. Most will then continue into a 2…
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Immune cell therapy takes on tough scleroderma
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether anti-CD19 CAR T-cell therapy can improve disease activity in adults with severe, treatment-resistant systemic sclerosis (SSc). The study will also assess the safety of this therapy and how CAR T-cells behave in the body. The…
Phase: PHASE2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Blood test could guide lung cancer treatment in new trial
Disease control Not yet recruitingExploring the efficacy and safety of adaptively adjusting treatment regimens based on ctDNA (MRD) status for EGFR mutation-positive NSCLC
Phase: PHASE2 • Sponsor: Anhui Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Miniature Nerve-Muscle models may reveal why some myasthenia gravis patients Don't improve
Knowledge-focused Recruiting nowMyasthenia gravis (MG) is an autoimmune disease in which autoantibodies attack the neuromuscular junction, the site at which nerve cells communicate with muscle fibres, impairing signal transmission and causing fluctuating muscle weakness that worsens with sustained activity. In …
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Brain implant that learns could help rare movement disorder
Disease control Recruiting nowThis is a single-center, open-label study designed to evaluate the feasibility, safety, and preliminary efficacy of cerebellar adaptive deep brain stimulation (aDBS) in adults with spinocerebellar ataxia type 6 (SCA6). A total of 5 participants will be enrolled. Participants wil…
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New Preservative-Free eye drop could match leading glaucoma treatment
Disease control Recruiting nowThis study is to establish non-inferiority of a preservative free formulation of Bimatoprost ophthalmic solution 0.01% (YSBP) of YS Life Science Co., Ltd. compared to LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of AbbVie INC in subjects with primary open angle glaucoma (POAG…
Phase: PHASE3 • Sponsor: YS Life Science Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC